Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.

Authors:
Shreya M Shah Elena V Demidova Randy W Lesh Michael J Hall Mary B Daly Joshua E Meyer Martin J Edelman Sanjeevani Arora

Cancer Treat Rev 2022 Mar 5;104:102337. Epub 2022 Jan 5.

Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, United States; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States. Electronic address:

DNA repair vulnerabilities are present in a significant proportion of cancers. Specifically, germline alterations in DNA repair not only increase cancer risk but are associated with treatment response and clinical outcomes. The therapeutic landscape of cancer has rapidly evolved with the FDA approval of therapies that specifically target DNA repair vulnerabilities. The clinical success of synthetic lethality between BRCA deficiency and poly(ADP-ribose) polymerase (PARP) inhibition has been truly revolutionary. Defective mismatch repair has been validated as a predictor of response to immune checkpoint blockade associated with durable responses and long-term benefit in many cancer patients. Advances in next generation sequencing technologies and their decreasing cost have supported increased genetic profiling of tumors coupled with germline testing of cancer risk genes in patients. The clinical adoption of panel testing for germline assessment in high-risk individuals has generated a plethora of genetic data, particularly on DNA repair genes. Here, we highlight the therapeutic relevance of germline aberrations in DNA repair to identify patients eligible for precision treatments such as PARP inhibitors (PARPis), immune checkpoint blockade, chemotherapy, radiation therapy and combined treatment. We also discuss emerging mechanisms that regulate DNA repair.

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ctrv.2021.102337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016579PMC
March 2022

Publication Analysis

Top Keywords

dna repair
28
immune checkpoint
8
repair vulnerabilities
8
cancer risk
8
repair
8
checkpoint blockade
8
dna
7
germline
5
cost supported
4
supported increased
4
increased genetic
4
genetic profiling
4
profiling tumors
4
regulate dna
4
tumors coupled
4
coupled germline
4
technologies decreasing
4
germline testing
4
testing cancer
4
risk genes
4

Keyword Occurance

Similar Publications

Comparative transcriptomics reveals circadian and pluripotency networks as two pillars of longevity regulation.

Authors:
J Yuyang Lu Matthew Simon Yang Zhao Julia Ablaeva Nancy Corson Yongwook Choi KayLene Y H Yamada Nicholas J Schork Wendy R Hood Geoffrey E Hill Richard A Miller Andrei Seluanov Vera Gorbunova

Cell Metab 2022 May 10. Epub 2022 May 10.

Department of Biology, University of Rochester, Rochester, NY 14627, USA. Electronic address:

Mammals differ more than 100-fold in maximum lifespan. Here, we conducted comparative transcriptomics on 26 species with diverse lifespans. We identified thousands of genes with expression levels negatively or positively correlated with a species' maximum lifespan (Neg- or Pos-MLS genes). Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Discovery, enantioselective synthesis of myrtucommulone E analogues as tyrosyl-DNA phosphodiesterase 2 inhibitors and their biological activities.

Authors:
Yu Zhang Hao Yang Fang-Ting Wang Xing Peng Hai-Yang Liu Qing-Jiang Li Lin-Kun An

Eur J Med Chem 2022 May 10;238:114445. Epub 2022 May 10.

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou, 510006, China. Electronic address:

As a recently discovered DNA repair enzyme, tyrosyl-DNA phosphodiesterase 2 (TDP2) can specifically repair topoisomerase 2 (TOP2)-mediated DNA damage, resulting in cancer cell resistance to TOP2 inhibitors. Its inhibitors can enhance the anticancer efficacy of TOP2 inhibitors. In this work, we report the discovery of natural product myrtucommulone E as selective TDP2 inhibitor and its first enantioselective total synthesis through a pivotal CPA-catalyzed Michael addition reaction. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Chromosomal synapsis defects can trigger oocyte apoptosis without elevating numbers of persistent DNA breaks above wild-type levels.

Authors:
Ramya Ravindranathan Kavya Raveendran Frantzeskos Papanikos Pedro A San-Segundo Attila Tóth

Nucleic Acids Res 2022 May 17. Epub 2022 May 17.

Institute of Physiological Chemistry, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.

Generation of haploid gametes depends on a modified version of homologous recombination in meiosis. Meiotic recombination is initiated by single-stranded DNA (ssDNA) ends originating from programmed DNA double-stranded breaks (DSBs) that are generated by the topoisomerase-related SPO11 enzyme. Meiotic recombination involves chromosomal synapsis, which enhances recombination-mediated DSB repair, and thus, crucially contributes to genome maintenance in meiocytes. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

DNA-PKcs-dependent phosphorylation of RECQL4 promotes NHEJ by stabilizing the NHEJ machinery at DNA double-strand breaks.

Authors:
Huiming Lu Junhong Guan Shih-Ya Wang Guo-Min Li Vilhelm A Bohr Anthony J Davis

Nucleic Acids Res 2022 May 17. Epub 2022 May 17.

Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Non-homologous end joining (NHEJ) is the major pathway that mediates the repair of DNA double-strand breaks (DSBs) generated by ionizing radiation (IR). Previously, the DNA helicase RECQL4 was implicated in promoting NHEJ, but its role in the pathway remains unresolved. In this study, we report that RECQL4 stabilizes the NHEJ machinery at DSBs to promote repair. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Histone demethylase JHDM2A participates in the repair of arsenic-induced DNA damage in L-02 cells by regulating DDB2.

Authors:
Changzhe Li Anliu Zhang Ting Hu Yue Yang Shunfang Tang Jun Li

Toxicol Ind Health 2022 May 17:7482337221098319. Epub 2022 May 17.

The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education Department of Toxicology, School of Public Health, 74628Guizhou Medical University, Guiyang, China.

Arsenic is widely present in nature and is a class I carcinogen confirmed by the World Health Organization and the International Agency for Research on Cancer. The liver is responsible for biotransformation in the body and is one of the major organs where arsenic accumulates in the body, but the mechanisms of arsenic-induced abnormal DNA damage repair pathways in the liver are still unclear. Recent studies have revealed that epigenetic mechanisms play an important role in arsenic-induced lesions. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}